Eintrag weiter verarbeiten
Risk, Timing, and Predictors of Disease Flare After Discontinuation of Anti–Tumor Necrosis Factor Therapy in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis With...
Gespeichert in:
| Zeitschriftentitel: | Arthritis & Rheumatology |
|---|---|
| Personen und Körperschaften: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| In: | Arthritis & Rheumatology, 70, 2018, 9, S. 1508-1518 |
| Format: | E-Article |
| Sprache: | Englisch |
| veröffentlicht: |
Wiley
|
| Schlagwörter: |
| author_facet |
Lovell, Daniel J. Johnson, Anne L. Huang, Bin Gottlieb, Beth S. Morris, Paula W. Kimura, Yukiko Onel, Karen Li, Suzanne C. Grom, Alexei A. Taylor, Janalee Brunner, Hermine I. Huggins, Jennifer L. Nocton, James J. Haines, Kathleen A. Edelheit, Barbara S. Shishov, Michael Jung, Lawrence K. Williams, Calvin B. Tesher, Melissa S. Costanzo, Denise M. Zemel, Lawrence S. Dare, Jason A. Passo, Murray H. Ede, Kaleo C. Olson, Judyann C. Cassidy, Elaine A. Griffin, Thomas A. Wagner‐Weiner, Linda Weiss, Jennifer E. Vogler, Larry B. Rouster‐Stevens, Kelly A. Beukelman, Timothy Cron, Randy Q. Kietz, Daniel Schikler, Kenneth Schmidt, Kara M. Mehta, Jay Wahezi, Dawn M. Ting, Tracy V. Verbsky, James W. Eberhard, B. Anne Spalding, Steven Chen, Chen Giannini, Edward H. Lovell, Daniel J. Johnson, Anne L. Huang, Bin Gottlieb, Beth S. Morris, Paula W. Kimura, Yukiko Onel, Karen Li, Suzanne C. Grom, Alexei A. Taylor, Janalee Brunner, Hermine I. Huggins, Jennifer L. Nocton, James J. Haines, Kathleen A. Edelheit, Barbara S. Shishov, Michael Jung, Lawrence K. Williams, Calvin B. Tesher, Melissa S. Costanzo, Denise M. Zemel, Lawrence S. Dare, Jason A. Passo, Murray H. Ede, Kaleo C. Olson, Judyann C. Cassidy, Elaine A. Griffin, Thomas A. Wagner‐Weiner, Linda Weiss, Jennifer E. Vogler, Larry B. Rouster‐Stevens, Kelly A. Beukelman, Timothy Cron, Randy Q. Kietz, Daniel Schikler, Kenneth Schmidt, Kara M. Mehta, Jay Wahezi, Dawn M. Ting, Tracy V. Verbsky, James W. Eberhard, B. Anne Spalding, Steven Chen, Chen Giannini, Edward H. |
|---|---|
| author |
Lovell, Daniel J. Johnson, Anne L. Huang, Bin Gottlieb, Beth S. Morris, Paula W. Kimura, Yukiko Onel, Karen Li, Suzanne C. Grom, Alexei A. Taylor, Janalee Brunner, Hermine I. Huggins, Jennifer L. Nocton, James J. Haines, Kathleen A. Edelheit, Barbara S. Shishov, Michael Jung, Lawrence K. Williams, Calvin B. Tesher, Melissa S. Costanzo, Denise M. Zemel, Lawrence S. Dare, Jason A. Passo, Murray H. Ede, Kaleo C. Olson, Judyann C. Cassidy, Elaine A. Griffin, Thomas A. Wagner‐Weiner, Linda Weiss, Jennifer E. Vogler, Larry B. Rouster‐Stevens, Kelly A. Beukelman, Timothy Cron, Randy Q. Kietz, Daniel Schikler, Kenneth Schmidt, Kara M. Mehta, Jay Wahezi, Dawn M. Ting, Tracy V. Verbsky, James W. Eberhard, B. Anne Spalding, Steven Chen, Chen Giannini, Edward H. |
| spellingShingle |
Lovell, Daniel J. Johnson, Anne L. Huang, Bin Gottlieb, Beth S. Morris, Paula W. Kimura, Yukiko Onel, Karen Li, Suzanne C. Grom, Alexei A. Taylor, Janalee Brunner, Hermine I. Huggins, Jennifer L. Nocton, James J. Haines, Kathleen A. Edelheit, Barbara S. Shishov, Michael Jung, Lawrence K. Williams, Calvin B. Tesher, Melissa S. Costanzo, Denise M. Zemel, Lawrence S. Dare, Jason A. Passo, Murray H. Ede, Kaleo C. Olson, Judyann C. Cassidy, Elaine A. Griffin, Thomas A. Wagner‐Weiner, Linda Weiss, Jennifer E. Vogler, Larry B. Rouster‐Stevens, Kelly A. Beukelman, Timothy Cron, Randy Q. Kietz, Daniel Schikler, Kenneth Schmidt, Kara M. Mehta, Jay Wahezi, Dawn M. Ting, Tracy V. Verbsky, James W. Eberhard, B. Anne Spalding, Steven Chen, Chen Giannini, Edward H. Arthritis & Rheumatology Risk, Timing, and Predictors of Disease Flare After Discontinuation of Anti–Tumor Necrosis Factor Therapy in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis With Clinically Inactive Disease Immunology Rheumatology Immunology and Allergy |
| author_sort |
lovell, daniel j. |
| spelling |
Lovell, Daniel J. Johnson, Anne L. Huang, Bin Gottlieb, Beth S. Morris, Paula W. Kimura, Yukiko Onel, Karen Li, Suzanne C. Grom, Alexei A. Taylor, Janalee Brunner, Hermine I. Huggins, Jennifer L. Nocton, James J. Haines, Kathleen A. Edelheit, Barbara S. Shishov, Michael Jung, Lawrence K. Williams, Calvin B. Tesher, Melissa S. Costanzo, Denise M. Zemel, Lawrence S. Dare, Jason A. Passo, Murray H. Ede, Kaleo C. Olson, Judyann C. Cassidy, Elaine A. Griffin, Thomas A. Wagner‐Weiner, Linda Weiss, Jennifer E. Vogler, Larry B. Rouster‐Stevens, Kelly A. Beukelman, Timothy Cron, Randy Q. Kietz, Daniel Schikler, Kenneth Schmidt, Kara M. Mehta, Jay Wahezi, Dawn M. Ting, Tracy V. Verbsky, James W. Eberhard, B. Anne Spalding, Steven Chen, Chen Giannini, Edward H. 2326-5191 2326-5205 Wiley Immunology Rheumatology Immunology and Allergy http://dx.doi.org/10.1002/art.40509 <jats:sec><jats:title>Objective</jats:title><jats:p>To determine the frequency, time to flare, and predictors of disease flare upon withdrawal of anti–tumor necrosis factor (anti‐<jats:styled-content style="fixed-case">TNF</jats:styled-content>) therapy in children with polyarticular forms of juvenile idiopathic arthritis (<jats:styled-content style="fixed-case">JIA</jats:styled-content>) who demonstrated ≥6 months of continuous clinically inactive disease.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>In 16 centers 137 patients with clinically inactive <jats:styled-content style="fixed-case">JIA</jats:styled-content> who were receiving anti‐<jats:styled-content style="fixed-case">TNF</jats:styled-content> therapy (42% of whom were also receiving methotrexate [<jats:styled-content style="fixed-case">MTX</jats:styled-content>]) were prospectively followed up. If the disease remained clinically inactive for the initial 6 months of the study, anti‐<jats:styled-content style="fixed-case">TNF</jats:styled-content> was stopped and patients were assessed for flare at 1, 2, 3, 4, 6, and 8 months. Life‐table analysis, <jats:italic>t</jats:italic>‐tests, chi‐square test, and Cox regression analysis were used to identify independent variables that could significantly predict flare by 8 months or time to flare.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>Of 137 patients, 106 (77%) maintained clinically inactive disease while receiving anti‐<jats:styled-content style="fixed-case">TNF</jats:styled-content> therapy for the initial 6 months and were included in the phase of the study in which anti‐<jats:styled-content style="fixed-case">TNF</jats:styled-content> therapy was stopped. Stopping anti‐<jats:styled-content style="fixed-case">TNF</jats:styled-content> resulted in disease flare in 39 (37%) of 106 patients by 8 months. The mean/median ± <jats:styled-content style="fixed-case">SEM</jats:styled-content> time to flare was 212/250 ± 9.77 days. Patients with shorter disease duration at enrollment, older age at onset and diagnosis, shorter disease duration prior to experiencing clinically inactive disease, and shorter time from onset of clinically inactive disease to enrollment were found to have significantly lower hazard ratios for likelihood of flare by 8 months (<jats:italic>P</jats:italic> < 0.05).</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>Over one‐third of patients with polyarticular <jats:styled-content style="fixed-case">JIA</jats:styled-content> with sustained clinically inactive disease will experience a flare by 8 months after discontinuation of anti‐<jats:styled-content style="fixed-case">TNF</jats:styled-content> therapy. Several predictors of lower likelihood of flare were identified.</jats:p></jats:sec> Risk, Timing, and Predictors of Disease Flare After Discontinuation of Anti–Tumor Necrosis Factor Therapy in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis With Clinically Inactive Disease Arthritis & Rheumatology |
| doi_str_mv |
10.1002/art.40509 |
| facet_avail |
Online Free |
| finc_class_facet |
Medizin |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAwMi9hcnQuNDA1MDk |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAwMi9hcnQuNDA1MDk |
| institution |
DE-Bn3 DE-Brt1 DE-Zwi2 DE-D161 DE-Gla1 DE-Zi4 DE-15 DE-Rs1 DE-Pl11 DE-105 DE-14 DE-Ch1 DE-L229 DE-D275 |
| imprint |
Wiley, 2018 |
| imprint_str_mv |
Wiley, 2018 |
| issn |
2326-5191 2326-5205 |
| issn_str_mv |
2326-5191 2326-5205 |
| language |
English |
| mega_collection |
Wiley (CrossRef) |
| match_str |
lovell2018risktimingandpredictorsofdiseaseflareafterdiscontinuationofantitumornecrosisfactortherapyinchildrenwithpolyarticularformsofjuvenileidiopathicarthritiswithclinicallyinactivedisease |
| publishDateSort |
2018 |
| publisher |
Wiley |
| recordtype |
ai |
| record_format |
ai |
| series |
Arthritis & Rheumatology |
| source_id |
49 |
| title |
Risk, Timing, and Predictors of Disease Flare After Discontinuation of Anti–Tumor Necrosis Factor Therapy in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis With Clinically Inactive Disease |
| title_unstemmed |
Risk, Timing, and Predictors of Disease Flare After Discontinuation of Anti–Tumor Necrosis Factor Therapy in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis With Clinically Inactive Disease |
| title_full |
Risk, Timing, and Predictors of Disease Flare After Discontinuation of Anti–Tumor Necrosis Factor Therapy in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis With Clinically Inactive Disease |
| title_fullStr |
Risk, Timing, and Predictors of Disease Flare After Discontinuation of Anti–Tumor Necrosis Factor Therapy in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis With Clinically Inactive Disease |
| title_full_unstemmed |
Risk, Timing, and Predictors of Disease Flare After Discontinuation of Anti–Tumor Necrosis Factor Therapy in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis With Clinically Inactive Disease |
| title_short |
Risk, Timing, and Predictors of Disease Flare After Discontinuation of Anti–Tumor Necrosis Factor Therapy in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis With Clinically Inactive Disease |
| title_sort |
risk, timing, and predictors of disease flare after discontinuation of anti–tumor necrosis factor therapy in children with polyarticular forms of juvenile idiopathic arthritis with clinically inactive disease |
| topic |
Immunology Rheumatology Immunology and Allergy |
| url |
http://dx.doi.org/10.1002/art.40509 |
| publishDate |
2018 |
| physical |
1508-1518 |
| description |
<jats:sec><jats:title>Objective</jats:title><jats:p>To determine the frequency, time to flare, and predictors of disease flare upon withdrawal of anti–tumor necrosis factor (anti‐<jats:styled-content style="fixed-case">TNF</jats:styled-content>) therapy in children with polyarticular forms of juvenile idiopathic arthritis (<jats:styled-content style="fixed-case">JIA</jats:styled-content>) who demonstrated ≥6 months of continuous clinically inactive disease.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>In 16 centers 137 patients with clinically inactive <jats:styled-content style="fixed-case">JIA</jats:styled-content> who were receiving anti‐<jats:styled-content style="fixed-case">TNF</jats:styled-content> therapy (42% of whom were also receiving methotrexate [<jats:styled-content style="fixed-case">MTX</jats:styled-content>]) were prospectively followed up. If the disease remained clinically inactive for the initial 6 months of the study, anti‐<jats:styled-content style="fixed-case">TNF</jats:styled-content> was stopped and patients were assessed for flare at 1, 2, 3, 4, 6, and 8 months. Life‐table analysis, <jats:italic>t</jats:italic>‐tests, chi‐square test, and Cox regression analysis were used to identify independent variables that could significantly predict flare by 8 months or time to flare.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>Of 137 patients, 106 (77%) maintained clinically inactive disease while receiving anti‐<jats:styled-content style="fixed-case">TNF</jats:styled-content> therapy for the initial 6 months and were included in the phase of the study in which anti‐<jats:styled-content style="fixed-case">TNF</jats:styled-content> therapy was stopped. Stopping anti‐<jats:styled-content style="fixed-case">TNF</jats:styled-content> resulted in disease flare in 39 (37%) of 106 patients by 8 months. The mean/median ± <jats:styled-content style="fixed-case">SEM</jats:styled-content> time to flare was 212/250 ± 9.77 days. Patients with shorter disease duration at enrollment, older age at onset and diagnosis, shorter disease duration prior to experiencing clinically inactive disease, and shorter time from onset of clinically inactive disease to enrollment were found to have significantly lower hazard ratios for likelihood of flare by 8 months (<jats:italic>P</jats:italic> < 0.05).</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>Over one‐third of patients with polyarticular <jats:styled-content style="fixed-case">JIA</jats:styled-content> with sustained clinically inactive disease will experience a flare by 8 months after discontinuation of anti‐<jats:styled-content style="fixed-case">TNF</jats:styled-content> therapy. Several predictors of lower likelihood of flare were identified.</jats:p></jats:sec> |
| container_issue |
9 |
| container_start_page |
1508 |
| container_title |
Arthritis & Rheumatology |
| container_volume |
70 |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792339930752483337 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T15:55:56.434Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Risk%2C+Timing%2C+and+Predictors+of+Disease+Flare+After+Discontinuation+of+Anti%E2%80%93Tumor+Necrosis+Factor+Therapy+in%C2%A0Children+With+Polyarticular+Forms+of+Juvenile+Idiopathic%C2%A0Arthritis+With+Clinically+Inactive+Disease&rft.date=2018-09-01&genre=article&issn=2326-5205&volume=70&issue=9&spage=1508&epage=1518&pages=1508-1518&jtitle=Arthritis+%26+Rheumatology&atitle=Risk%2C+Timing%2C+and+Predictors+of+Disease+Flare+After+Discontinuation+of+Anti%E2%80%93Tumor+Necrosis+Factor+Therapy+in%C2%A0Children+With+Polyarticular+Forms+of+Juvenile+Idiopathic%C2%A0Arthritis+With+Clinically+Inactive+Disease&aulast=Giannini&aufirst=Edward+H.&rft_id=info%3Adoi%2F10.1002%2Fart.40509&rft.language%5B0%5D=eng |
| SOLR | |
| _version_ | 1792339930752483337 |
| author | Lovell, Daniel J., Johnson, Anne L., Huang, Bin, Gottlieb, Beth S., Morris, Paula W., Kimura, Yukiko, Onel, Karen, Li, Suzanne C., Grom, Alexei A., Taylor, Janalee, Brunner, Hermine I., Huggins, Jennifer L., Nocton, James J., Haines, Kathleen A., Edelheit, Barbara S., Shishov, Michael, Jung, Lawrence K., Williams, Calvin B., Tesher, Melissa S., Costanzo, Denise M., Zemel, Lawrence S., Dare, Jason A., Passo, Murray H., Ede, Kaleo C., Olson, Judyann C., Cassidy, Elaine A., Griffin, Thomas A., Wagner‐Weiner, Linda, Weiss, Jennifer E., Vogler, Larry B., Rouster‐Stevens, Kelly A., Beukelman, Timothy, Cron, Randy Q., Kietz, Daniel, Schikler, Kenneth, Schmidt, Kara M., Mehta, Jay, Wahezi, Dawn M., Ting, Tracy V., Verbsky, James W., Eberhard, B. Anne, Spalding, Steven, Chen, Chen, Giannini, Edward H. |
| author_facet | Lovell, Daniel J., Johnson, Anne L., Huang, Bin, Gottlieb, Beth S., Morris, Paula W., Kimura, Yukiko, Onel, Karen, Li, Suzanne C., Grom, Alexei A., Taylor, Janalee, Brunner, Hermine I., Huggins, Jennifer L., Nocton, James J., Haines, Kathleen A., Edelheit, Barbara S., Shishov, Michael, Jung, Lawrence K., Williams, Calvin B., Tesher, Melissa S., Costanzo, Denise M., Zemel, Lawrence S., Dare, Jason A., Passo, Murray H., Ede, Kaleo C., Olson, Judyann C., Cassidy, Elaine A., Griffin, Thomas A., Wagner‐Weiner, Linda, Weiss, Jennifer E., Vogler, Larry B., Rouster‐Stevens, Kelly A., Beukelman, Timothy, Cron, Randy Q., Kietz, Daniel, Schikler, Kenneth, Schmidt, Kara M., Mehta, Jay, Wahezi, Dawn M., Ting, Tracy V., Verbsky, James W., Eberhard, B. Anne, Spalding, Steven, Chen, Chen, Giannini, Edward H., Lovell, Daniel J., Johnson, Anne L., Huang, Bin, Gottlieb, Beth S., Morris, Paula W., Kimura, Yukiko, Onel, Karen, Li, Suzanne C., Grom, Alexei A., Taylor, Janalee, Brunner, Hermine I., Huggins, Jennifer L., Nocton, James J., Haines, Kathleen A., Edelheit, Barbara S., Shishov, Michael, Jung, Lawrence K., Williams, Calvin B., Tesher, Melissa S., Costanzo, Denise M., Zemel, Lawrence S., Dare, Jason A., Passo, Murray H., Ede, Kaleo C., Olson, Judyann C., Cassidy, Elaine A., Griffin, Thomas A., Wagner‐Weiner, Linda, Weiss, Jennifer E., Vogler, Larry B., Rouster‐Stevens, Kelly A., Beukelman, Timothy, Cron, Randy Q., Kietz, Daniel, Schikler, Kenneth, Schmidt, Kara M., Mehta, Jay, Wahezi, Dawn M., Ting, Tracy V., Verbsky, James W., Eberhard, B. Anne, Spalding, Steven, Chen, Chen, Giannini, Edward H. |
| author_sort | lovell, daniel j. |
| container_issue | 9 |
| container_start_page | 1508 |
| container_title | Arthritis & Rheumatology |
| container_volume | 70 |
| description | <jats:sec><jats:title>Objective</jats:title><jats:p>To determine the frequency, time to flare, and predictors of disease flare upon withdrawal of anti–tumor necrosis factor (anti‐<jats:styled-content style="fixed-case">TNF</jats:styled-content>) therapy in children with polyarticular forms of juvenile idiopathic arthritis (<jats:styled-content style="fixed-case">JIA</jats:styled-content>) who demonstrated ≥6 months of continuous clinically inactive disease.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>In 16 centers 137 patients with clinically inactive <jats:styled-content style="fixed-case">JIA</jats:styled-content> who were receiving anti‐<jats:styled-content style="fixed-case">TNF</jats:styled-content> therapy (42% of whom were also receiving methotrexate [<jats:styled-content style="fixed-case">MTX</jats:styled-content>]) were prospectively followed up. If the disease remained clinically inactive for the initial 6 months of the study, anti‐<jats:styled-content style="fixed-case">TNF</jats:styled-content> was stopped and patients were assessed for flare at 1, 2, 3, 4, 6, and 8 months. Life‐table analysis, <jats:italic>t</jats:italic>‐tests, chi‐square test, and Cox regression analysis were used to identify independent variables that could significantly predict flare by 8 months or time to flare.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>Of 137 patients, 106 (77%) maintained clinically inactive disease while receiving anti‐<jats:styled-content style="fixed-case">TNF</jats:styled-content> therapy for the initial 6 months and were included in the phase of the study in which anti‐<jats:styled-content style="fixed-case">TNF</jats:styled-content> therapy was stopped. Stopping anti‐<jats:styled-content style="fixed-case">TNF</jats:styled-content> resulted in disease flare in 39 (37%) of 106 patients by 8 months. The mean/median ± <jats:styled-content style="fixed-case">SEM</jats:styled-content> time to flare was 212/250 ± 9.77 days. Patients with shorter disease duration at enrollment, older age at onset and diagnosis, shorter disease duration prior to experiencing clinically inactive disease, and shorter time from onset of clinically inactive disease to enrollment were found to have significantly lower hazard ratios for likelihood of flare by 8 months (<jats:italic>P</jats:italic> < 0.05).</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>Over one‐third of patients with polyarticular <jats:styled-content style="fixed-case">JIA</jats:styled-content> with sustained clinically inactive disease will experience a flare by 8 months after discontinuation of anti‐<jats:styled-content style="fixed-case">TNF</jats:styled-content> therapy. Several predictors of lower likelihood of flare were identified.</jats:p></jats:sec> |
| doi_str_mv | 10.1002/art.40509 |
| facet_avail | Online, Free |
| finc_class_facet | Medizin |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAwMi9hcnQuNDA1MDk |
| imprint | Wiley, 2018 |
| imprint_str_mv | Wiley, 2018 |
| institution | DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Rs1, DE-Pl11, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275 |
| issn | 2326-5191, 2326-5205 |
| issn_str_mv | 2326-5191, 2326-5205 |
| language | English |
| last_indexed | 2024-03-01T15:55:56.434Z |
| match_str | lovell2018risktimingandpredictorsofdiseaseflareafterdiscontinuationofantitumornecrosisfactortherapyinchildrenwithpolyarticularformsofjuvenileidiopathicarthritiswithclinicallyinactivedisease |
| mega_collection | Wiley (CrossRef) |
| physical | 1508-1518 |
| publishDate | 2018 |
| publishDateSort | 2018 |
| publisher | Wiley |
| record_format | ai |
| recordtype | ai |
| series | Arthritis & Rheumatology |
| source_id | 49 |
| spelling | Lovell, Daniel J. Johnson, Anne L. Huang, Bin Gottlieb, Beth S. Morris, Paula W. Kimura, Yukiko Onel, Karen Li, Suzanne C. Grom, Alexei A. Taylor, Janalee Brunner, Hermine I. Huggins, Jennifer L. Nocton, James J. Haines, Kathleen A. Edelheit, Barbara S. Shishov, Michael Jung, Lawrence K. Williams, Calvin B. Tesher, Melissa S. Costanzo, Denise M. Zemel, Lawrence S. Dare, Jason A. Passo, Murray H. Ede, Kaleo C. Olson, Judyann C. Cassidy, Elaine A. Griffin, Thomas A. Wagner‐Weiner, Linda Weiss, Jennifer E. Vogler, Larry B. Rouster‐Stevens, Kelly A. Beukelman, Timothy Cron, Randy Q. Kietz, Daniel Schikler, Kenneth Schmidt, Kara M. Mehta, Jay Wahezi, Dawn M. Ting, Tracy V. Verbsky, James W. Eberhard, B. Anne Spalding, Steven Chen, Chen Giannini, Edward H. 2326-5191 2326-5205 Wiley Immunology Rheumatology Immunology and Allergy http://dx.doi.org/10.1002/art.40509 <jats:sec><jats:title>Objective</jats:title><jats:p>To determine the frequency, time to flare, and predictors of disease flare upon withdrawal of anti–tumor necrosis factor (anti‐<jats:styled-content style="fixed-case">TNF</jats:styled-content>) therapy in children with polyarticular forms of juvenile idiopathic arthritis (<jats:styled-content style="fixed-case">JIA</jats:styled-content>) who demonstrated ≥6 months of continuous clinically inactive disease.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>In 16 centers 137 patients with clinically inactive <jats:styled-content style="fixed-case">JIA</jats:styled-content> who were receiving anti‐<jats:styled-content style="fixed-case">TNF</jats:styled-content> therapy (42% of whom were also receiving methotrexate [<jats:styled-content style="fixed-case">MTX</jats:styled-content>]) were prospectively followed up. If the disease remained clinically inactive for the initial 6 months of the study, anti‐<jats:styled-content style="fixed-case">TNF</jats:styled-content> was stopped and patients were assessed for flare at 1, 2, 3, 4, 6, and 8 months. Life‐table analysis, <jats:italic>t</jats:italic>‐tests, chi‐square test, and Cox regression analysis were used to identify independent variables that could significantly predict flare by 8 months or time to flare.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>Of 137 patients, 106 (77%) maintained clinically inactive disease while receiving anti‐<jats:styled-content style="fixed-case">TNF</jats:styled-content> therapy for the initial 6 months and were included in the phase of the study in which anti‐<jats:styled-content style="fixed-case">TNF</jats:styled-content> therapy was stopped. Stopping anti‐<jats:styled-content style="fixed-case">TNF</jats:styled-content> resulted in disease flare in 39 (37%) of 106 patients by 8 months. The mean/median ± <jats:styled-content style="fixed-case">SEM</jats:styled-content> time to flare was 212/250 ± 9.77 days. Patients with shorter disease duration at enrollment, older age at onset and diagnosis, shorter disease duration prior to experiencing clinically inactive disease, and shorter time from onset of clinically inactive disease to enrollment were found to have significantly lower hazard ratios for likelihood of flare by 8 months (<jats:italic>P</jats:italic> < 0.05).</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>Over one‐third of patients with polyarticular <jats:styled-content style="fixed-case">JIA</jats:styled-content> with sustained clinically inactive disease will experience a flare by 8 months after discontinuation of anti‐<jats:styled-content style="fixed-case">TNF</jats:styled-content> therapy. Several predictors of lower likelihood of flare were identified.</jats:p></jats:sec> Risk, Timing, and Predictors of Disease Flare After Discontinuation of Anti–Tumor Necrosis Factor Therapy in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis With Clinically Inactive Disease Arthritis & Rheumatology |
| spellingShingle | Lovell, Daniel J., Johnson, Anne L., Huang, Bin, Gottlieb, Beth S., Morris, Paula W., Kimura, Yukiko, Onel, Karen, Li, Suzanne C., Grom, Alexei A., Taylor, Janalee, Brunner, Hermine I., Huggins, Jennifer L., Nocton, James J., Haines, Kathleen A., Edelheit, Barbara S., Shishov, Michael, Jung, Lawrence K., Williams, Calvin B., Tesher, Melissa S., Costanzo, Denise M., Zemel, Lawrence S., Dare, Jason A., Passo, Murray H., Ede, Kaleo C., Olson, Judyann C., Cassidy, Elaine A., Griffin, Thomas A., Wagner‐Weiner, Linda, Weiss, Jennifer E., Vogler, Larry B., Rouster‐Stevens, Kelly A., Beukelman, Timothy, Cron, Randy Q., Kietz, Daniel, Schikler, Kenneth, Schmidt, Kara M., Mehta, Jay, Wahezi, Dawn M., Ting, Tracy V., Verbsky, James W., Eberhard, B. Anne, Spalding, Steven, Chen, Chen, Giannini, Edward H., Arthritis & Rheumatology, Risk, Timing, and Predictors of Disease Flare After Discontinuation of Anti–Tumor Necrosis Factor Therapy in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis With Clinically Inactive Disease, Immunology, Rheumatology, Immunology and Allergy |
| title | Risk, Timing, and Predictors of Disease Flare After Discontinuation of Anti–Tumor Necrosis Factor Therapy in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis With Clinically Inactive Disease |
| title_full | Risk, Timing, and Predictors of Disease Flare After Discontinuation of Anti–Tumor Necrosis Factor Therapy in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis With Clinically Inactive Disease |
| title_fullStr | Risk, Timing, and Predictors of Disease Flare After Discontinuation of Anti–Tumor Necrosis Factor Therapy in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis With Clinically Inactive Disease |
| title_full_unstemmed | Risk, Timing, and Predictors of Disease Flare After Discontinuation of Anti–Tumor Necrosis Factor Therapy in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis With Clinically Inactive Disease |
| title_short | Risk, Timing, and Predictors of Disease Flare After Discontinuation of Anti–Tumor Necrosis Factor Therapy in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis With Clinically Inactive Disease |
| title_sort | risk, timing, and predictors of disease flare after discontinuation of anti–tumor necrosis factor therapy in children with polyarticular forms of juvenile idiopathic arthritis with clinically inactive disease |
| title_unstemmed | Risk, Timing, and Predictors of Disease Flare After Discontinuation of Anti–Tumor Necrosis Factor Therapy in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis With Clinically Inactive Disease |
| topic | Immunology, Rheumatology, Immunology and Allergy |
| url | http://dx.doi.org/10.1002/art.40509 |